Drug of last resort

From WikiMD's Food, Medicine & Wellnesspedia

Drug of Last Resort is a term used in the medical field to describe a pharmaceutical drug that is given to a patient after all other treatment options have failed to produce an adequate response. These drugs are typically used as a final attempt to treat a condition and are often associated with a higher risk of side effects or complications due to their potent nature. The use of a drug of last resort is generally considered only when the benefits outweigh the potential risks for the patient.

Definition[edit | edit source]

A Drug of Last Resort is defined as a medication or therapeutic agent that is prescribed to patients after all conventional treatment options have been exhausted without success. This can include situations where the patient has not responded to standard treatments, has experienced intolerable side effects, or when the disease has progressed to a stage where conventional therapies are no longer effective.

Indications[edit | edit source]

The indication for the use of a drug of last resort varies widely depending on the condition being treated. Common scenarios include advanced stages of cancer, autoimmune diseases, multi-drug resistant infections, and severe mental health conditions. In each case, the decision to use such a drug is made with careful consideration of the patient's current health status, the potential benefits of the drug, and the risks associated with its use.

Examples[edit | edit source]

Some well-known examples of drugs of last resort include:

  • Clostridium difficile infections: Fecal microbiota transplant (FMT) is considered a treatment of last resort for recurrent C. difficile infections after antibiotics have failed.
  • Cancer: Certain chemotherapeutic agents or experimental drugs may be used as a last resort when standard treatments have been ineffective.
  • Rheumatoid arthritis: Biologic drugs, such as TNF inhibitors, are often considered drugs of last resort due to their potential side effects and cost.
  • Multi-drug-resistant tuberculosis (MDR-TB): Newer antibiotics, like bedaquiline and delamanid, are used as last-resort treatments for MDR-TB.

Considerations[edit | edit source]

Before prescribing a drug of last resort, healthcare providers must consider several factors:

  • Efficacy and Safety: The potential benefits of the drug must significantly outweigh the risks.
  • Patient's Condition: The severity and progression of the patient's condition are critical in deciding whether to use a drug of last resort.
  • Alternative Options: All other reasonable treatment options should have been considered or attempted.
  • Informed Consent: Patients must be fully informed about the potential risks and benefits of the drug and consent to its use.

Ethical and Legal Considerations[edit | edit source]

The use of drugs of last resort raises ethical and legal considerations, including the right to try experimental drugs, access to potentially life-saving treatments, and the cost implications for healthcare systems. Healthcare providers must navigate these issues while ensuring the patient's best interests are at the forefront of any decision-making process.

Conclusion[edit | edit source]

Drugs of last resort represent a critical component of modern medical treatment, offering hope in seemingly hopeless situations. However, their use requires careful consideration of the ethical, legal, and medical implications to ensure the best possible outcome for the patient.

‎ ‎


Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.


Contributors: Admin, Prab R. Tumpati, MD